TipRanks
CombiGene AB (DE:COJ0)
FRANKFURT:COJ0
Germany Market
COJ0
CombiGene AB
RESEARCH TOOLSreports

CombiGene AB (COJ0) Income Statement

0 Followers

CombiGene AB Income Statement

Last quarter (Q2 2026), CombiGene AB's total revenue was kr50.00K, a decrease of -142.02% from the same quarter last year. In Q2, CombiGene AB's net income was kr610.50K. See CombiGene AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 326.00Kkr 5.54Mkr 26.70Mkr 84.04M
Gross Profit
kr -8.16Mkr -46.78Mkr -21.29Mkr -19.20Mkr 15.16M
Operating Expenses
kr 4.81Mkr 31.25Mkr 18.77Mkr 3.11Mkr 15.59M
Depreciation and Amortization
kr 5.79Mkr 13.00Mkr 329.34Kkr 300.00Kkr 2.60M
EBITDA
kr -7.19Mkr -34.22Mkr -35.98Mkr -5.86Mkr 23.56M
Operating Income
kr -12.98Mkr -47.22Mkr -38.60Mkr -6.95Mkr 20.96M
Other Income/Expenses
kr 617.00Kkr 2.34Mkr 2.94Mkr 790.14Kkr 24.00
Pretax Income
kr -12.36Mkr -44.88Mkr -35.66Mkr -6.16Mkr 20.96M
Net Income
kr -12.36Mkr -44.88Mkr -35.66Mkr -6.16Mkr 20.96M
Per Share Metrics
Basic EPS
kr -0.62kr -2.27kr -1.80kr -0.31kr 1.21
Diluted EPS
kr -0.62kr -2.27kr -1.80kr -0.31kr 1.21
Weighted Average Shares Outstanding
 19.80M 19.80M 19.80M 19.80M 17.31M
Weighted Average Shares Outstanding (Diluted)
 19.80M 19.80M 19.80M 19.80M 17.31M
Currency in SEK

CombiGene AB Earnings and Revenue History